Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
First Trust Capital Strength ETF (FTCS)
Investment Objective/Strategy - The First Trust Capital Strength ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called The Capital Strength IndexSM.
There can be no assurance that the Fund's investment objectives will be achieved.
Index Description According to the Index Provider
  • A security must be a common stock or REIT that is a member of the NASDAQ US Benchmark Index. The largest 500 securities by float-adjusted market capitalization with a minimum three-month average daily dollar trading volume of $5 million are selected. Multiple share classes of the same issuer are excluded.
  • To be eligible for inclusion in the Index, companies must have:
    • at least $1 billion in cash or short term investments.
    • a long term debt to market cap ratio less than 30%.
    • a return on equity greater than 15%.
  • Eligible companies are then ranked by a combined short-term (3 months) and long-term (12 months) realized volatility.
  • The 50 companies with the lowest combined volatility score are selected for inclusion in the Index.
  • A maximum weight of 30% in any one Industry Classification Benchmark industry is allowed. If an industry has a weight greater than 30%, the highest ranking security by volatility will be removed and replaced with the next eligible security from a different industry. This process is repeated until no industry has a weight greater than 30%.
  • The Index stocks are equally weighted initially and on each rebalancing effective date. The index is reconstituted and rebalanced on a quarterly basis.
Fund Overview
Fund TypeLarge Cap Core
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
Fiscal Year-End12/31
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.55%
Net Expense Ratio*0.55%
* As of 5/2/2022
Expenses are capped contractually at 0.65% per year, at least through April 30, 2023.
Current Fund Data (as of 10/3/2022)
Closing NAV1$68.11
Closing Market Price2$68.12
Bid/Ask Midpoint$68.11
Bid/Ask Discount0.01%
30-Day Median Bid/Ask Spread (as of 9/30/2022)30.04%
Total Net Assets$7,638,248,847
Outstanding Shares112,150,002
Daily Volume552,790
Average 30-Day Daily Volume373,514
Closing Market Price 52-Week High/Low$84.75 / $66.42
Closing NAV 52-Week High/Low$84.72 / $66.28
Number of Holdings (excluding cash)50
Top Holdings (as of 9/30/2022)*
Holding Percent
Regeneron Pharmaceuticals, Inc. 2.40%
Trane Technologies Plc 2.36%
Nasdaq, Inc. 2.29%
Automatic Data Processing, Inc. 2.23%
Cummins Inc. 2.19%
Air Products and Chemicals, Inc. 2.18%
W.R. Berkley Corporation 2.16%
Northrop Grumman Corporation 2.15%
Amphenol Corporation 2.14%